Literature DB >> 15386761

QUOTE-gene(ca): development of a counselee-centered instrument to measure needs and preferences in genetic counseling for hereditary cancer.

Arwen Pieterse1, Sandra van Dulmen, Margreet Ausems, Angela Schoemaker, Frits Beemer, Jozien Bensing.   

Abstract

Counselees' motives for seeking genetic counseling for hereditary cancer have already been investigated, however not using instruments based on counselees' perspective. In addition, expectations regarding the process of counseling have scarcely been assessed. This article describes the construction and psychometric properties of the QUOTE-gene(ca), a counselee-centered instrument intended to measure needs and preferences in genetic counseling for hereditary cancer. Formulation of the items involved input from counselees and the instrument was derived from a conceptual framework for measuring patient satisfaction. Two-hundred new counselees completed a questionnaire containing the instrument and measures of coping style (TMSI), generalized anxiety (STAI) and cancer-related stress reactions (IES), prior to their first consultation. Results showed that the instrument captures relevant issues of concern with high internal consistency, and was associated, as expected, with validated measures of coping style and distress. Responses showed that major concerns prior to counseling relate to: receiving information about risk and preventive strategies; the procedure of counseling; and preferences on how the interaction with the counselor proceeds. Receiving emotional support and discussing emotional aspects were considered relatively less important. Increasing insight into individual needs may help counselors in better addressing these concerns, potentially increasing the likelihood of successful counseling. Copyright (c) 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15386761     DOI: 10.1002/pon.853

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  19 in total

1.  Genetic testing and counseling for hereditary neurological diseases in Mali.

Authors:  Katherine Gloria Meilleur; Souleymane Coulibaly; Moussa Traoré; Guida Landouré; Alison La Pean; Modibo Sangaré; Fanny Mochel; Siona Traoré; Kenneth H Fischbeck; Hae-Ra Han
Journal:  J Community Genet       Date:  2011-02-22

2.  Use and evaluation of an individually tailored website for counselees prior to breast cancer genetic counseling.

Authors:  Akke Albada; Margreet G E M Ausems; Roel Otten; Jozien M Bensing; Sandra van Dulmen
Journal:  J Cancer Educ       Date:  2011-12       Impact factor: 2.037

3.  A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.

Authors:  Akke Albada; Sandra van Dulmen; Dick Lindhout; Jozien M Bensing; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

4.  Breast cancer genetic counselling referrals: how comparable are the findings between the UK and the Netherlands?

Authors:  Akke Albada; Julie Werrett; Sandra Van Dulmen; Jozien M Bensing; Cyril Chapman; Margreet G E M Ausems; Alison Metcalfe
Journal:  J Community Genet       Date:  2011-08-18

Review 5.  Monitoring style of coping with cancer related threats: a review of the literature.

Authors:  Pagona Roussi; Suzanne M Miller
Journal:  J Behav Med       Date:  2014-02-02

6.  What information do cancer genetic counselees prioritize?

Authors:  Afsaneh Hayat Roshanai; Claudia Lampic; Charlotta Ingvoldstad; Marie Stenmark Askmalm; Chathrine Bjorvatn; Richard Rosenquist; Karin Nordin
Journal:  J Genet Couns       Date:  2011-10-13       Impact factor: 2.537

7.  Development of E-info gene(ca): a website providing computer-tailored information and question prompt prior to breast cancer genetic counseling.

Authors:  Akke Albada; Sandra van Dulmen; Roel Otten; Jozien M Bensing; Margreet G E M Ausems
Journal:  J Genet Couns       Date:  2009-05-14       Impact factor: 2.537

8.  Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.

Authors:  Aisha S Sie; Judith B Prins; Liesbeth Spruijt; C Marleen Kets; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

9.  More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.

Authors:  Aisha S Sie; Wendy A G van Zelst-Stams; Liesbeth Spruijt; Arjen R Mensenkamp; Marjolijn J L Ligtenberg; Han G Brunner; Judith B Prins; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

10.  The Influence of Online Health Information Seeking Before a Consultation on Anxiety, Satisfaction, and Information Recall, Mediated by Patient Participation: Field Study.

Authors:  Melanie de Looper; Julia C M van Weert; Barbara C Schouten; Sifra Bolle; Eric H J Belgers; Eric H Eddes; Ellen M A Smets
Journal:  J Med Internet Res       Date:  2021-07-05       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.